GABA Therapeutics, Inc Employee Directory

Biotechnology ResearchCalifornia, United States2-10 Employees

GABA Therapeutics, Inc. is a clinical‑stage biotechnology company based in Newport Beach, California, focused on developing GRX-917 to treat anxiety and depression. The program is described as fast-acting with minimal side effects and non-addictive, and it aims to raise neurosteroids naturally, a mechanism that could also benefit a broader range of neuropsychiatric and neurological disorders. The company operates with a small team and concentrates its efforts on early-stage clinical work.

Its target market consists of patients seeking rapid relief from anxiety and depression, with an emphasis on safety and reduced dependence compared with existing therapies. In March 2023, the company reported positive final results from a Phase 1 trial of GRX-917. Earlier, in 2022, GABA Therapeutics announced the appointment of Mario David Saltarelli, M.D., Ph.D., as Chief Executive Officer and Chief Medical Officer.

Sign up for free to view info

Company overview Email format